Colombia Flavonoids Market Size & Outlook, 2025-2033
Colombia Flavonoids Market Insights
- Deep Market Insights analysis indicates that the Colombia Flavonoids Market size, valued at USD 13.2 Million in 2024, is expected to expand to USD 23.54 Million by 2033.
- The Colombia market is forecasted to expand at a CAGR of 6.57% spanning 2026–2033.
- Flavonols held the leading position among Compound Type segments in 2024, based on market size.
- Flavonols is projected to post the fastest growth rate, sustaining its position as the most attractive Compound Type segment during the forecast horizon.
![Colombia Flavonoids Market Size, Share & Growth Analysis By [2033]](https://deepmarketinsights.com/uploads/charts/colombia-flavonoids-market-colombia-compound-type-226556.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Colombia contributed 0.68% to the global Flavonoids Market size in 2024.
- By 2033, United States is forecasted to remain the largest global market for Flavonoids Market.
- In LATAM, Brazil is projected to capture the leading share of market size by 2033.
- Among LATAM markets, Brazil is expected to post the fastest growth, reaching USD 136 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 13.2 Million |
| Market Size In 2033 | USD 23.54 Million |
| Largest segment | Flavonols |
| Units | Revenue in USD Million |
| CAGR | 6.57% (2025-2033) |
| Segmnetation Covered | |
| Compound Type |
|
| Source |
|
| End Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Colombia Flavonoids Market Compound Type 2025-2033 (USD Million)
| Compound Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Flavonols | XX.x | XX.x | XX.x | 5.88 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Flavanones | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Anthocyanins | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Isoflavones | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Colombia Flavonoids Market Source 2025-2033 (USD Million)
| Source | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citrus Fruits | XX.x | XX.x | XX.x | 6.22 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Berries | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Vegetables | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Botanical Extracts | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Colombia Flavonoids Market End Use 2025-2033 (USD Million)
| End Use | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dietary Supplements | XX.x | XX.x | XX.x | 5.92 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Functional Food | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Beverages | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cosmetics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.